Related Experiment Video
Updated: Oct 28, 2025

09:29
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
11.7K
Post-COVID Neuromyelitis Optica Spectrum Disorder
Shumaila Rafique1, Areeba Wasim1, Tipu Sultan1
1Department of Pediatric Neurology, The Children Hospital, Lahore, Pakistan.
Summary
Severe acute respiratory syndrome (SARS) may trigger neuromyelitis optica spectrum disorder (NMOSD). This case study reports NMOSD in a pediatric patient following SARS-CoV-2 infection, suggesting a potential link between the virus and this autoimmune disorder.
Area of Science:
- Neurology
- Immunology
- Infectious Diseases
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, has been linked to various immune-mediated disorders.
- Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune condition affecting the central nervous system, often triggered by infections.
Observation:
- This report details a pediatric case of NMOSD.
- The patient had a preceding infection with SARS-CoV-2.
Findings:
- The findings suggest a potential causal relationship between SARS-CoV-2 infection and the development of NMOSD in this pediatric patient.
- The study highlights the role of Aquaporin 4 (AQP-4) antibodies in NMOSD pathogenesis.
Implications:
- This case underscores the importance of considering SARS-CoV-2 as a potential trigger for NMOSD, even in pediatric populations.
- Further research is needed to elucidate the mechanisms linking viral infections to autoimmune demyelinating diseases like NMOSD.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
2.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.2K
Myasthenia Gravis: Diagnostic Tests
1.5K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.5K

